NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Supplement·Evidence index

Apigenin and Melatonin: what the published research says

PubMed indexes 5 records that name Apigenin and Melatonin together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Apigenin and Melatonin. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

5 studies naming Apigenin and Melatonin.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Comparative Protective Effects of Melatonin and Apigenin Against Paclitaxel-Induced Testicular Injury in Rats: Oxidative Stress, DNA Damage, Apoptosis, and NF-κB Signaling.

Nutrients · 2026 · PMID 42197101

Comparative StudyAnimal study

“Paclitaxel-induced testicular injury is mediated by a coordinated interplay of oxidative stress, apoptosis, inflammation, and structural degeneration. Melatonin and apigenin effectively mitigate these processes, with apigenin exhibiting context-dependent antioxidant activity. These findings suggest that melatonin and apigenin may serve as adjunctive strategies for preserving male reproductive function during chemotherapy.”

Saydam et al. · Authors' conclusion

Names both Apigenin and Melatonin in its title.

Retracted: Histologic evaluation of new bone in post-extraction sockets induced by melatonin and apigenin: an experimental study in American fox hound dogs.

Clinical oral implants research · 2018 · PMID 27191920

Retracted Publication

“Topical applications of either melatonin or apigenin have a potential to accelerate bone tissue in early healing stages; melatonin was seen to have stimulated bone maturation to a greater extent at the 60 days of follow-up.”

Calvo-Guirado et al. · Authors' conclusion

Names both Apigenin and Melatonin in its title.

Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug.

Journal of ethnopharmacology · 2024 · PMID 38447616

Meta-AnalysisReviewHuman subjects

“The discovery of the beneficial effects of these natural active compounds in POL supports the idea that POL could be a promising novel candidate for the treatment and prevention of inflammation-related cancers of the digestive system. However, clinical data describing the mode of action of the naturally active compounds of POL are still lacking.”

Shao et al. · Authors' conclusion

Names Apigenin and Melatonin together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Apigenin, Melatonin, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.